The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson-Leger, C.
Right arrow Articles by Klaus, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson-Leger, C.
Right arrow Articles by Klaus, G. G.

The Journal of Immunology, Vol 159, Issue 3 1150-1159, Copyright © 1997 by American Association of Immunologists


ARTICLES

The effects of IFN-gamma on CD40-mediated activation of B cells from X- linked immunodeficient or normal mice

C Johnson-Leger, J Hasbold, M Holman and GG Klaus
Division of Cellular Immunology, National Institute for Medical Research, London, United Kingdom.

B cell activation induced by cross-linking of CD40 is enhanced by costimulation with certain T cell-derived cytokines (generally Th2 type), most notably IL-4. We show here that the induction of DNA synthesis in normal mouse B cells by anti-CD40 mAb is also significantly enhanced by supernatants from anti-CD3-activated Th1 cells or from primary T cells. In both instances the costimulatory activity is specifically abrogated by neutralizing Abs against IFN- gamma. B cells from CBA/N immunodeficient (xid) mice are markedly hyporesponsive to most anti-CD40 Abs, even in the presence of IL-4. These cells do, however, synthesize DNA when stimulated by anti-CD40 plus supernatants from anti-CD3-stimulated primary T cells, by anti- CD40 plus IFN-gamma (but not IL-4), or by fixed, activated Th1 T cells. In all these instances, the mitogenic response of xid B cells is crucially dependent on the presence of IFN-gamma. This cytokine also enhanced CD40-induced homotypic adhesion of normal and xid B cells and potentiated CD40-mediated protection of B cells from spontaneous apoptosis. These data, therefore, indicate that IFN-gamma plays an essential role in the activation of B cells by Th1 T cells and by naive T cells during the initiation of primary Ab responses. The results with CBA/N B cells further suggest that the xid mutation selectively affects their capacity to respond to Th2-derived signals, for reasons that remain unclear.


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. L. Fields, S. A. Nish, B. D. Hondowicz, M. H. Metzgar, G. N. Wharton, A. J. Caton, and J. Erikson
The Influence of Effector T Cells and Fas Ligand on Lupus-Associated B Cells
J. Immunol., July 1, 2005; 175(1): 104 - 111.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Hasbold, J. S.-Y. Hong, M. R. Kehry, and P. D. Hodgkin
Integrating Signals from IFN-{gamma} and IL-4 by B Cells: Positive and Negative Effects on CD40 Ligand-Induced Proliferation, Survival, and Division-Linked Isotype Switching to IgG1, IgE, and IgG2a
J. Immunol., October 15, 1999; 163(8): 4175 - 4181.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
G. G. B. Klaus, M. Holman, C. Johnson-Leger, J. R. Christenson, and M. R. Kehry
Interaction of B cells with activated T cells reduces the threshold for CD40-mediated B cell activation
Int. Immunol., January 1, 1999; 11(1): 71 - 79.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Nonoyama, S. Tsukada, T. Yamadori, T. Miyawaki, Y. Z. Jin, C. Watanabe, T. Morio, J.-I. Yata, and H. D. Ochs
Functional Analysis of Peripheral Blood B Cells in Patients with X-Linked Agammaglobulinemia
J. Immunol., October 15, 1998; 161(8): 3925 - 3929.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.